Product Description
Overall, the global powered morcellator market was valued at just under $99 million in 2023. This is expected to increase over the forecast period at a CAGR of 2% to reach over $113 million.
Throughout this medical market research, we analyzed over 10 powered morcellator companies globally and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2029, and Historical Data to 2019
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Powered Morcellator Market Insights
Global Powered Morcellator Market Share Insights
- LiNA Medical held the top position in both the worldwide disposable powered morcellator market and the broader global powered morcellator sector. Internationally renowned, this Polish firm elevated its XCISE™ powered morcellators to widespread recognition.
- Following closely, Karl Storz emerged as the second-leading contender in the global powered morcellator market. Its dominance was primarily established through a significant share in the reposable segment.
- Securing the third position was BOWA Medical, a notable competitor in this arena. Their Ergo 300® reposable device, featuring a reusable handle paired with disposable blades, marked their presence. Additionally, the company supplied blades not only for their own branded morcellators but also for those of other brands in the market.
Market Segmentation Summary
- Disposable Powered Morcellators
- Reposable Powered Morcellators
- Reusable Powered Morcellators
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |

